Streetbeat News

KHRNF

Khiron Life Sciences Corp

https://khiron.ca/

Industry

Pharmaceutical Preparation Manufacturing

Open

0.00

Mkt cap

515M

Volume

15K

High

0.00

P/E Ratio

N/A

52-wk high

0.02

Low

0.00

Div yield

N/A

52-wk low

0.00

Microsoft shares rise as the company reports better-than-expected Q1 2025 GAAP EPS and sales.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 8:05 pm

Banzai has been granted an extension by the Nasdaq Hearing Panel to regain compliance with listing requirements.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 12:34 pm

The article discusses the potential for cannabis legalization in Venezuela amid political turmoil and election fraud allegations. It highlights the successes of Colombia's cannabis industry and mentions companies like Clever Leaves Holdings Inc, Khiron Life Sciences Corp, and PharmaCielo Ltd as examples of successful cannabis businesses in Colombia.

Portfolio Pulse from Patricio Liddle

July 31, 2024 | 1:02 pm

The cannabis sector experienced significant volatility on July 5, 2024, with notable gainers and losers. Key gainers included Cara Therapeutics (NASDAQ:CARA) and Eastside Distilling (NASDAQ:EAST), while major losers included Cronos Group (NASDAQ:CRON) and GrowGeneration (NASDAQ:GRWG).

Portfolio Pulse from Benzinga Insights

July 05, 2024 | 8:30 pm

Marijuana stocks saw significant movements on Monday, with Khiron Life Sciences and CordovaCann among the top gainers. Notable gainers include Cara Therapeutics, Greenlane Holdings, and 22nd Century Group. On the losing side, Affinor Growers and Heritage Cannabis Holding experienced substantial declines.

Portfolio Pulse from Benzinga Insights

June 24, 2024 | 8:30 pm

Cannabis stocks showed significant movement on May 8, 2024, with Khiron Life Sciences leading the gainers with a 9900.00% increase, while The Flowr experienced a drastic 99.00% decline. Other notable movers include Affinor Growers, Eastside Distilling, and 4Front Ventures on the gainers' side, and Charlottes Web Holdings, Kaya Holdings, and Elixinol Wellness among the losers. The market saw a mix of dramatic ups and downs, reflecting the volatile nature of the cannabis industry.

Portfolio Pulse from Benzinga Insights

May 08, 2024 | 8:30 pm

Marijuana stocks saw significant movement on April 17, 2024, with notable gainers including Green Growth Brands and Elixinol Wellness, and losers like Khiron Life Sciences and Item 9 Labs. The movements reflect volatility in the cannabis sector, impacting companies listed on both OTC and major exchanges like NASDAQ and NYSE.

Portfolio Pulse from Benzinga Insights

April 17, 2024 | 8:30 pm

Cannabis stocks experienced significant movements on April 10, 2024, with notable gainers including Khiron Life Sciences, Heritage Cannabis, and Village Farms International. Losers of the day included Item 9 Labs, SOL Global Investments, and Scotts Miracle Gro. The movements reflect volatility in the cannabis market, impacting investors and companies alike.

Portfolio Pulse from Benzinga Insights

April 10, 2024 | 8:30 pm

Marijuana stocks experienced significant movement with ESCO Technologies, Maple Leaf Green World, and others among top gainers. Notably, ESCO Technologies closed up 110173.68% at $104.76. Conversely, Khiron Life Sciences and Choom Holdings were among the top losers, with Khiron closing down 99.99%. The article highlights the volatile nature of marijuana stocks, showcasing both substantial gains and losses within the sector.

Portfolio Pulse from Benzinga Insights

February 16, 2024 | 9:30 pm

Marijuana stock movements on February 15, 2024, saw significant gains and losses across the board. ESCO Technologies led the gainers with an unprecedented rise, while EVIO topped the losers with a drastic fall. Notable companies like Aurora Cannabis and OrganiGram Holdings experienced significant drops, whereas Scotts Miracle Gro and Cronos Group saw modest gains.

Portfolio Pulse from Benzinga Insights

February 15, 2024 | 9:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.